Royal Bank of Canada
MATN

Royal Bank of Canada’s Mateon Therapeutics, Inc. MATN Stock Holding History

Royal Bank of Canada’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-94
Closed – – 6954
2016
Q3 		$0 Hold
94
– – ﹤0.01% 6755
2016
Q2 		$0 Buy
+94
New +$67 ﹤0.01% 6708

Other funds holding MATN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Royal Bank of Canada's MATN Position: Q4 2016 in Review

Royal Bank of Canada sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 94 shares.

Royal Bank of Canada first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Royal Bank of Canada reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 94 Mateon Therapeutics, Inc. shares in Q4 2016.
  • Royal Bank of Canada first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Royal Bank of Canada's Mateon Therapeutics, Inc. position peaked at $0 in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.